Ari Robicsek
Impact in
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria
- Endocrinology top 0.1%
- Enterobacteriaceae and Cronobacter Research
- Escherichia coli research studies
Papers in
-
- Antibiotic Use and Resistance 11
-
- Antibiotic Resistance in Bacteria 18
- Co-authors
- David C. HooperGeorge A. JacobyJacob StrahilevitzLance R. PetersonChi Hye ParkRichard B. ThomsonDonna M. HacekDaniel F. Sahm
- Journals
- Infection Control and Hospital Epidemiology (11 papers)Antimicrobial Agents and Chemotherapy (10 papers)American Journal of Infection Control (8 papers)Open Forum Infectious Diseases (7 papers)Clinical Infectious Diseases (5 papers)
- Partner nations
- United StatesCanadaIsrael
In The Last Decade
Ari Robicsek
90 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Molecular Medicine 3.8k
- Endocrinology 1.6k
- Applied Microbiology and Biotechnology 542
- Clinical Biochemistry 941
- Pollution 1.3k
Countries citing papers authored by Ari Robicsek
This map shows the geographic impact of Ari Robicsek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ari Robicsek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ari Robicsek more than expected).
Fields of papers citing papers by Ari Robicsek
This network shows the impact of papers produced by Ari Robicsek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ari Robicsek. The network helps show where Ari Robicsek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ari Robicsek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 6 | |
| 3 | 2022 | 37 | |
| 4 | 2020 | 2 | |
| 5 | 2018 | 40 | |
| 6 | 2016 | 2 | |
| 7 | 2014 | 191 | |
| 8 | 2014 | 1 | |
| 9 | 2012 | 78 | |
| 10 | 2012 | 18 | |
| 11 | 2010 | 28 | |
| 12 | 2008 | 25 | |
| 13 | Impact of Test Characteristics on an MRSA Surveillance Program | 2008 | 3 |
| 14 | 2007 | 42 | |
| 15 | 2006 | 477 | |
| 16 | Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying Enzyme Hit paper breakdown → | 2006 | 631 |
| 17 | Progression to MRSA Infection in Asymptomatic Carriers (AC) Detected through a Hospital-Based Universal Surveillance and Decolonization Program | 2006 | 2 |
| 18 | Impact of Universal Inpatient Surveillance and Decolonization (USD) on Rates of Healthcare Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infection (BSI) | 2006 | 1 |
| 19 | The worldwide emergence of plasmid-mediated quinolone resistance Hit paper breakdown → | 2006 | 699 |
| 20 | Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase Hit paper breakdown → | 2005 | 750 |
About Ari Robicsek
Ari Robicsek is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Infectious Diseases and Endocrinology, having authored 91 papers that have together received 7.1k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (26 papers), Bacterial Identification and Susceptibility Testing (20 papers), Antibiotic Resistance in Bacteria (18 papers), Clostridium difficile and Clostridium perfringens research (12 papers), Antibiotic Use and Resistance (11 papers), SARS-CoV-2 and COVID-19 Research (8 papers), Pneumonia and Respiratory Infections (8 papers) and Urinary Tract Infections Management (8 papers). The work is most often cited by research in Molecular Medicine (3.8k citations), Endocrinology (1.6k citations), Applied Microbiology and Biotechnology (542 citations), Clinical Biochemistry (941 citations) and Pollution (1.3k citations). Ari Robicsek has collaborated with scholars based in United States, Canada and Israel. Frequent co-authors include David C. Hooper, George A. Jacoby, Jacob Strahilevitz, Lance R. Peterson, Chi Hye Park, Richard B. Thomson, Donna M. Hacek, Daniel F. Sahm, Jennifer L. Beaumont and D.F. Sahm. Their work appears in journals such as Infection Control and Hospital Epidemiology, Antimicrobial Agents and Chemotherapy, American Journal of Infection Control, Open Forum Infectious Diseases and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.